Exact Sciences
EXAS
#1179
Rank
HK$151.84 B
Marketcap
HK$799.55
Share price
0.04%
Change (1 day)
83.14%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2025 (TTM): -HK$7.54 Billion

According to Exact Sciences's latest financial reports the company's current earnings are HK$3.08 Billion. In 2024 the company made an earning of -HK$7.94 Billion a decrease over its 2023 earnings that were of -HK$1.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$7.54 Billion-5.05%
2024 -HK$7.94 Billion435.05%
2023 -HK$1.49 Billion-69.18%
2022 -HK$4.82 Billion-25.77%
2021 -HK$6.49 Billion1.68%
2020 -HK$6.38 Billion271.17%
2019 -HK$1.72 Billion58.99%
2018 -HK$1.09 Billion20.89%
2017 -HK$0.9 Billion-30.95%
2016 -HK$1.3 Billion5.09%
2015 -HK$1.24 Billion57.24%
2014 -HK$0.79 Billion116.53%
2013 -HK$0.37 Billion
2011 -HK$0.23 Billion143.73%
2010 -HK$92.4 Million27.85%
2009 -HK$72.27 Million0.27%
2008 -HK$72.08 Million-20.95%
2007 -HK$91.18 Million-13.53%
2006 -HK$0.11 Billion-10.07%
2005 -HK$0.12 Billion-21.81%
2004 -HK$0.15 Billion-33.44%
2003 -HK$0.23 Billion-6.51%
2002 -HK$0.25 Billion17.95%
2001 -HK$0.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
HK$71.09 B-1,038.16%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
HK$0.19 B-102.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
HK$0.51 B-106.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$3.27 Billion-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-HK$0.28 Billion-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA